<SEC-DOCUMENT>0001171843-25-003910.txt : 20250616
<SEC-HEADER>0001171843-25-003910.hdr.sgml : 20250616
<ACCEPTANCE-DATETIME>20250616161349
ACCESSION NUMBER:		0001171843-25-003910
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20250611
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250616
DATE AS OF CHANGE:		20250616

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOCRYST PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000882796
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				621413174
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-23186
		FILM NUMBER:		251050225

	BUSINESS ADDRESS:	
		STREET 1:		4505 EMPEROR BOULEVARD
		STREET 2:		SUITE 200
		CITY:			DURHAM
		STATE:			NC
		ZIP:			27703
		BUSINESS PHONE:		919-859-1302

	MAIL ADDRESS:	
		STREET 1:		4505 EMPEROR BOULEVARD
		STREET 2:		SUITE 200
		CITY:			DURHAM
		STATE:			NC
		ZIP:			27703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8k_061625.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:bcrx="http://globenewswire.com/20250611">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_03B_bcrx_globenewswire.com_20250611 -->
<!-- Field: Set; Name: xdx; ID: xdx_044_20250611_20250611 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DEntityCentralIndexKey_0000882796 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-06-11" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-06-11" id="Fact000004" name="dei:EntityCentralIndexKey">0000882796</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="bcrx-20250611.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-06-11">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000882796</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-06-11</xbrli:startDate>
        <xbrli:endDate>2025-06-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><span style="font-family: Sans-Serif; font-size: 9pt; color: Red"><b></b></span><b><span style="font-size: 10pt">UNITED STATES</span></b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">FORM <span id="xdx_907_edei--DocumentType_c20250611__20250611_zYcRPRzgOjk"><ix:nonNumeric contextRef="AsOf2025-06-11" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b>CURRENT REPORT</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b>Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">Date of Report (Date of earliest event reported): <span id="xdx_907_edei--DocumentPeriodEndDate_c20250611__20250611_zWdQYOXv9nF9"><ix:nonNumeric contextRef="AsOf2025-06-11" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">June 11, 2025</ix:nonNumeric></span></p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 18pt; text-align: center"><b><span id="xdx_90E_edei--EntityRegistrantName_c20250611__20250611_zuyxT3Sn1GXk"><ix:nonNumeric contextRef="AsOf2025-06-11" id="Fact000011" name="dei:EntityRegistrantName">BioCryst Pharmaceuticals, Inc.</ix:nonNumeric></span></b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">(Exact name of registrant as specified in charter)</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="width: 33%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_908_edei--EntityIncorporationStateCountryCode_c20250611__20250611_zlicUp506yc6"><ix:nonNumeric contextRef="AsOf2025-06-11" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="width: 34%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90A_edei--EntityFileNumber_c20250611__20250611_z7X6EUnqGv1c"><ix:nonNumeric contextRef="AsOf2025-06-11" id="Fact000013" name="dei:EntityFileNumber">000-23186</ix:nonNumeric></span></b></span></td>
    <td style="width: 33%; padding-left: 16.5pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_907_edei--EntityTaxIdentificationNumber_c20250611__20250611_ze6f5skwDgd4"><ix:nonNumeric contextRef="AsOf2025-06-11" id="Fact000014" name="dei:EntityTaxIdentificationNumber">62-1413174</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 10pt">(State or Other Jurisdiction <span style="font-size: 10pt">of Incorporation)</span></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">(Commission <span style="font-size: 10pt">File Number)</span></span></td>
    <td style="padding-left: 17.5pt; text-align: center"><span style="font-size: 10pt">(IRS Employer <span style="font-size: 10pt">Identification No.)</span> </span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><b><span id="xdx_906_edei--EntityAddressAddressLine1_c20250611__20250611_z9rAgHs4zTMj"><ix:nonNumeric contextRef="AsOf2025-06-11" id="Fact000015" name="dei:EntityAddressAddressLine1">4505 Emperor Blvd.</ix:nonNumeric></span>, <span id="xdx_903_edei--EntityAddressAddressLine2_c20250611__20250611_za4Sn5jd0681"><ix:nonNumeric contextRef="AsOf2025-06-11" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite 200</ix:nonNumeric></span></b></p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><b><span id="xdx_90C_edei--EntityAddressCityOrTown_c20250611__20250611_zC4bNFmnZJB2"><ix:nonNumeric contextRef="AsOf2025-06-11" id="Fact000017" name="dei:EntityAddressCityOrTown">Durham</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressStateOrProvince_c20250611__20250611_z1pkU3BKYEhc"><ix:nonNumeric contextRef="AsOf2025-06-11" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">North Carolina</ix:nonNumeric></span> <span id="xdx_902_edei--EntityAddressPostalZipCode_c20250611__20250611_z62KyNV92qd2"><ix:nonNumeric contextRef="AsOf2025-06-11" id="Fact000019" name="dei:EntityAddressPostalZipCode">27703</ix:nonNumeric></span></b></p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0">(Address of Principal Executive Offices) (Zip Code)</p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><b><span id="xdx_905_edei--CityAreaCode_c20250611__20250611_z1K9EIGf8hpa"><ix:nonNumeric contextRef="AsOf2025-06-11" id="Fact000020" name="dei:CityAreaCode">(919)</ix:nonNumeric></span> <span id="xdx_906_edei--LocalPhoneNumber_c20250611__20250611_zi1KjONLbaKl"><ix:nonNumeric contextRef="AsOf2025-06-11" id="Fact000021" name="dei:LocalPhoneNumber">859-1302</ix:nonNumeric></span></b></p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><b></b>(Registrant&#8217;s telephone number, including area
code)</p>


<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">________________________________________</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">(Former name or former address, if changed since last report.)</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 1pt 0pt 0; font-size: 10pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="margin: 0pt 1pt 0pt 0; font-size: 10pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 8.5pt"/><td style="width: 24.5pt"><span id="xdx_90E_edei--WrittenCommunications_c20250611__20250611_zJw7JDtOdAUg"><ix:nonNumeric contextRef="AsOf2025-06-11" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></td><td>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr></table>

<table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 8.5pt"/><td style="width: 24.5pt"><span id="xdx_905_edei--SolicitingMaterial_c20250611__20250611_zOdqkjAcV7Ab"><ix:nonNumeric contextRef="AsOf2025-06-11" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></td><td>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td></tr></table>

<table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 8.5pt"/><td style="width: 24.5pt"><span id="xdx_904_edei--PreCommencementTenderOffer_c20250611__20250611_zWco5N2PtZhf"><ix:nonNumeric contextRef="AsOf2025-06-11" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></td><td>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td></tr></table>

<table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 8.5pt"/><td style="width: 24.5pt"><span id="xdx_904_edei--PreCommencementIssuerTenderOffer_c20250611__20250611_zcItWnzSMq17"><ix:nonNumeric contextRef="AsOf2025-06-11" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></td><td>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</td></tr></table>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="border: Black 1pt solid; width: 33%; text-align: center"><span style="font-size: 10pt">Title of each class</span></td>
    <td style="border-top: Black 1pt solid; width: 35%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">Trading Symbol(s)</span></td>
    <td style="border-top: Black 1pt solid; width: 32%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">Name of each exchange on which registered</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90D_edei--Security12bTitle_c20250611__20250611_zR9HcUsLJRi5"><ix:nonNumeric contextRef="AsOf2025-06-11" id="Fact000026" name="dei:Security12bTitle">Common Stock</ix:nonNumeric></span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_900_edei--TradingSymbol_c20250611__20250611_zh3aNF79HhAg"><ix:nonNumeric contextRef="AsOf2025-06-11" id="Fact000027" name="dei:TradingSymbol">BCRX</ix:nonNumeric></span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90B_edei--SecurityExchangeName_c20250611__20250611_zMamfZJm57Fg"><ix:nonNumeric contextRef="AsOf2025-06-11" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq Global Select Market</ix:nonNumeric></span></b></span></td></tr>
  </table>
<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 19pt 0pt 0; font-size: 10pt">Indicate by check mark whether the registrant is an emerging growth company as defined
in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).</p>

<p style="margin: 0pt 19pt 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: right">Emerging growth company <span id="xdx_902_edei--EntityEmergingGrowthCompany_c20250611__20250611_zbE3j3fzJ8Gc"><ix:nonNumeric contextRef="AsOf2025-06-11" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: right">&#160;</p>

<p style="margin: 0pt 7pt 0pt 0; font-size: 10pt">If an emerging growth company, indicate by check mark if the registrant has elected
not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section
13(a) of the Exchange Act. &#9744;</p>

<p style="margin: 0pt 7pt 0pt 0; font-size: 10pt">&#160;</p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 4pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 7pt 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt"><b>Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment
of Certain Officers; Compensatory Arrangements of Certain Officers.</b></p>

<p style="margin: 0pt 0; font-size: 10pt"><b>&#160;</b></p>

<p style="margin: 0pt 0; font-size: 10pt"><i>Departure of Director</i></p>

<p style="margin: 0pt 0; font-size: 10pt"><b>&#160;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">On June 11, 2025, George B. Abercrombie notified BioCryst Pharmaceuticals,
Inc., a Delaware corporation (the &#8220;Company&#8221;), of his intention to retire from the Board of Directors of the Company (the &#8220;Board&#8221;),
effective as of the Company&#8217;s 2025 Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;). Prior to his retirement, Mr.
Abercrombie served as a member of the Board&#8217;s Audit Committee, Commercialization Committee, and Corporate Governance and Nominating
Committee. Mr. Abercrombie cited no disagreement with the Board or management relating to the Company, its operations, policies, or practices.
The Company is grateful to Mr. Abercrombie for his more than 13 years of service on the Board and appreciates his many contributions to
the Company.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify"><i>Amended and Restated Stock Incentive Plan</i></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">On June 12, 2025, at the Company&#8217;s Annual Meeting, the Company&#8217;s
stockholders approved, by the affirmative vote of a majority of the shares of the Company&#8217;s common stock represented in person or
by proxy at the Annual Meeting and voting on the proposal, a proposal to amend and restate the BioCryst Pharmaceuticals, Inc. Stock Incentive
Plan (such plan, as amended and restated, the &#8220;Stock Incentive Plan&#8221;), increasing the number of shares available for issuance
under the Stock Incentive Plan by 11,000,000 shares (the &#8220;Incentive Plan Proposal&#8221;). A detailed description of the Stock Incentive
Plan is included in the Company&#8217;s proxy statement for the Annual Meeting. The description of the Stock Incentive Plan in this report
does not purport to be complete and is qualified in its entirety by reference to the full text of the Stock Incentive Plan, a copy of
which is filed as Exhibit 10.1 hereto and is incorporated herein by reference.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify"><b>&#160;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify"><b>Item 5.07. Submission of Matters to a Vote of Security Holders.</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">The Annual Meeting was held on June 12, 2025 for the purpose of (1) electing
two directors to serve for a term ending at the Company&#8217;s 2028 annual meeting of stockholders and until a successor is duly elected
and qualified; (2) ratifying the selection of Ernst &amp; Young LLP as the Company&#8217;s independent registered public accountants for
2025; (3) holding a non-binding, advisory vote approving the Company&#8217;s executive compensation; and (4) approving the Incentive Plan
Proposal described in Item 5.02 above.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">The nominees for director were elected by the following votes:</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="margin-left: auto; width: 80%; border-collapse: collapse; font-size: 10pt; margin-right: auto">
  <tr style="vertical-align: top">
    <td style="width: 52%; text-align: justify">&#160;</td>
    <td style="width: 3%; text-align: justify">&#160;</td>
    <td style="width: 21%; text-align: center"><span style="text-decoration: underline">FOR</span></td>
    <td style="width: 4%; text-align: justify">&#160;</td>
    <td style="width: 20%; text-align: center"><span style="text-decoration: underline">WITHHELD</span></td></tr>
  <tr style="vertical-align: top">
    <td style="background-color: #CCECFF; text-align: justify"><span style="background-color: #CCECFF">Steven K. Galson, M.D., MPH</span></td>
    <td style="background-color: #CCEEFF; text-align: justify">&#160;</td>
    <td style="border-bottom: Black 1pt solid; background-color: #CCEEFF; text-align: center">146,067,707</td>
    <td style="background-color: #CCEEFF; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; background-color: #CCEEFF; text-align: center">3,688,084</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="background-color: white">Alan G. Levin</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">146,065,836</td>
    <td style="text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">3,689,955</td></tr>
  </table>
<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">In addition, there were 29,272,898 broker non-votes for each director.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">The proposed ratification of the selection of Ernst &amp; Young LLP as
the Company&#8217;s independent registered public accountants for 2025 was approved by the following votes:</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="margin-left: auto; width: 70%; border-collapse: collapse; font-size: 10pt; margin-right: auto">
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="width: 66%; text-align: justify">FOR</td>
    <td style="border-bottom: Black 1pt solid; width: 34%; text-align: right">174,697,892</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">AGAINST</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">3,838,292</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify">ABSTAIN</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">492,505</td></tr>
  </table>
<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">The proposed non-binding, advisory resolution regarding executive compensation
was approved by the following votes:</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="margin-left: auto; width: 70%; border-collapse: collapse; font-size: 10pt; margin-right: auto">
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="width: 66%; text-align: justify">FOR</td>
    <td style="border-bottom: Black 1pt solid; width: 34%; text-align: right">143,096,094</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">AGAINST</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">6,357,577</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify">ABSTAIN</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">302,120</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">BROKER NON-VOTES</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">29,272,898</td></tr>
  </table>
<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 4pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">The Incentive Plan Proposal was approved by the following votes:</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="margin-left: auto; width: 70%; border-collapse: collapse; font-size: 10pt; margin-right: auto">
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="width: 66%; text-align: justify">FOR</td>
    <td style="border-bottom: Black 1pt solid; width: 34%; text-align: right">110,230,306</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">AGAINST</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">38,875,495</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify">ABSTAIN</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">649,990</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">BROKER NON-VOTES</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">29,272,898</td></tr>
  </table>
<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">There was no other business voted upon at the Annual Meeting.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify"><b>Item 9.01. Financial Statements and Exhibits</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify"><i>(d) Exhibits.</i></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td><span style="text-decoration: underline"><b>Exhibit No.</b></span></td><td style="text-align: justify"><span style="text-decoration: underline"><b>Description</b></span></td></tr>
                                                                                                                 <tr style="vertical-align: top">
<td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
                                                                                                                 <tr style="vertical-align: top">
<td style="width: 1in"><a href="exh_101.htm">10.1</a></td><td style="text-align: justify"><a href="exh_101.htm">BioCryst Pharmaceuticals, Inc. Stock Incentive Plan (as amended and restated as of April 21, 2025).</a></td></tr></table>

<p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify; text-indent: -1in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 1in">104</td><td style="text-align: justify">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr></table>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b>&#160;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b>&#160;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b>&#160;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b>&#160;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b>&#160;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b>&#160;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b>&#160;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b>&#160;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b>&#160;</b></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 4pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b>&#160;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b>SIGNATURE</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><b>&#160;</b></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="text-align: justify">Date:&#160;&#160;June 16, 2025</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: justify"><b>BioCryst Pharmaceuticals, Inc.</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 33%; text-align: justify">&#160;</td>
    <td style="width: 18%; text-align: justify">&#160;</td>
    <td style="width: 4%">
    <p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>
    <p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>
    <p style="margin: 0pt 0; font-size: 10pt; text-align: justify">By:</p></td>
    <td style="border-bottom: Black 1pt solid; width: 45%">
    <p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>
    <p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>
    <p style="margin: 0pt 0; font-size: 10pt; text-align: justify">/s/ Alane Barnes</p></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">Alane Barnes</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><p style="margin-top: 0; margin-bottom: 0">&#160;&#160;</p></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">Chief Legal Officer</td></tr>
  </table>
<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 100%"><div style="border-top: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKwjAMRb9g/xD6PLQduIe96VARp8gQ8bW4TIpbM9I69ZP8S+uGGAIhuffkChGLNa1MgwznRVnAEduu0R6hxBoZ7QWDI99sMwizxKtxnrX1w/oDcwoMBiadyEu4D87eOKwykOlUpdNkBkpmSsJ8J6KvnpOtTYXWG92AthUcmDo26DW/xg9H/SRL7WtIOiE7QzYDNZGj/IZEqgT21OsH8c1BUeQiioeKxJrp3gXX8unRfklYNtiGODfS/44+wARKSA== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>exh_101.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>BIOCRYST PHARMACEUTICALS, INC.<BR>
STOCK INCENTIVE PLAN<BR>
(AS AMENDED AND RESTATED AS OF APRIL 21, 2025)</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="color: windowtext">ARTICLE
One</FONT><U><BR>
GENERAL PROVISIONS</U></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: windowtext">I.</FONT></TD><TD STYLE="text-align: justify">PURPOSES OF THE PLAN</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">A.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>This Stock Incentive Plan (the &ldquo;Plan&rdquo;), formerly the &ldquo;BioCryst Pharmaceuticals, Inc. 1991 Stock Option
Plan,&rdquo; is intended to promote the interests of BioCryst Pharmaceuticals, Inc., a Delaware corporation (the &ldquo;Company&rdquo;),
by providing a method whereby (i) employees (including officers and directors) of the Company (or its parent or subsidiary corporations),
(ii) non-employee members of the board of directors of the Company (the &ldquo;Board&rdquo;) (or of any parent or subsidiary corporations)
and (iii) consultants and other independent contractors who provide valuable services to the Company (or any parent or subsidiary corporations)
may be offered the opportunity to acquire a proprietary interest, or otherwise increase their proprietary interest, in the Company as
an incentive for them to remain in the service of the Company (or any parent or subsidiary corporations).</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">B.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>For purposes of the Plan, the following provisions shall be applicable in determining the parent and subsidiary corporations
of the Company:</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in"><FONT STYLE="color: windowtext">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Any corporation (other than the Company) in an unbroken chain of corporations ending with the Company shall be considered
to be a <B>parent </B>corporation of the Company, provided each such corporation in the unbroken chain (other than the Company) owns,
at the time of the determination, stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock
in one of the other corporations in such chain.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in"><FONT STYLE="color: windowtext">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Each corporation (other than the Company) in an unbroken chain of corporations beginning with the Company shall be considered
to be a <B>subsidiary</B> of the Company, provided each such corporation (other than the last corporation) in the unbroken chain owns,
at the time of the determination, stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock
in one of the other corporations in such chain.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">C.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Plan, as amended and restated, was approved and adopted by the Board, effective on April 21, 2025, in order to increase
by 11,000,000 the number of shares of the Company&rsquo;s common stock, par value $0.01 per share (the &ldquo;Common Stock&rdquo;), available
for issuance under the Plan, subject to approval by the Company&rsquo;s stockholders at the Company&rsquo;s Annual Meeting of Stockholders
on June 12, 2025, and to make certain other changes.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: windowtext">II.</FONT></TD><TD STYLE="text-align: justify">STRUCTURE OF THE PLAN</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">A.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Plan shall be divided into three separate equity programs:</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in"><FONT STYLE="color: windowtext">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>the Discretionary Option Grant Program specified in Article Two, pursuant to which eligible persons may, at the discretion
of the Plan Administrator, be granted options to purchase shares of Common Stock,</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in"><FONT STYLE="color: windowtext">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>the Stock Issuance Program specified in Article Three, pursuant to which eligible persons may, at the discretion of the
Plan Administrator, be issued shares of Common Stock directly or through the issuance of restricted stock units (&ldquo;RSUs&rdquo;) that
provide for the issuance of shares of Common Stock if the applicable vesting criteria are satisfied, and</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in"><FONT STYLE="color: windowtext">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>the Director Grant Program specified in Article Four, pursuant to which non-employee members of the Board may receive grants
of awards.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">B.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Unless the context clearly indicates otherwise, the provisions of Articles One and Five of the Plan shall apply to all equity
programs under the Plan and shall accordingly govern the interests of all individuals under the Plan.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: windowtext">III.</FONT></TD><TD STYLE="text-align: justify">ADMINISTRATION OF THE PLAN</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">A.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Plan shall be administered by the Committee who shall be the Compensation Committee of the Board or, in the absence
of a Compensation Committee, a properly constituted committee or the Board itself (the administrator is referred to herein as the &ldquo;Committee&rdquo;
or the &ldquo;Plan Administrator&rdquo;). Any power of the Committee may also be exercised by the Board, except to the extent that the
grant or exercise of such authority would cause any award or transaction to become subject to (or lose an exemption under) the short-swing
profit recovery provisions of Section 16 of the Securities Exchange Act of 1934, as amended (the &ldquo;1934 Act&rdquo;). To the extent
that any permitted action taken by the Board conflicts with action taken by the Committee, the Board action shall control. The Committee
may by resolution authorize one or more officers of the Company to perform any or all things that the Committee is authorized and empowered
to do or perform under the Plan, and for all purposes under this Plan, such officer or officers shall be treated as the Committee; provided,
however, that the resolution so authorizing such officer or officers shall specify the total number of awards (if any) such officer or
officers may award pursuant to such delegated authority, and any such award shall be subject to the form of award agreement theretofore
approved by the Compensation Committee. No such officer shall designate himself or herself as a recipient of any awards granted under
authority delegated to such officer. In addition, the Compensation Committee may delegate any or all aspects of the day-to-day administration
of the Plan to one or more officers or employees of the Company or any subsidiary or affiliate, and/or to one or more agents.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">B.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Subject to the express provisions of this Plan, the Committee shall be authorized and empowered to do all things that it
determines to be necessary or appropriate in connection with the administration of this Plan, including, without limitation: (i) to prescribe,
amend and rescind rules and regulations relating to this Plan and to define terms not otherwise defined herein; (ii) to determine which
persons are grantees, to which of such grantees, if any, awards shall be granted hereunder and the timing of any such awards; (iii) to
grant awards to grantees and determine the terms and conditions thereof, including the number of shares of Common Stock subject to awards
and the exercise or purchase price of such shares and the circumstances under which awards become exercisable or vested or are forfeited
or expire, which terms may but need not be conditioned upon the passage of time, continued employment, the satisfaction of performance
criteria, the occurrence of certain events (including events which constitute a Change in Control to the extent permitted hereunder),
or other factors; (iv) to establish and verify the extent of satisfaction of any performance goals or other conditions applicable to the
grant, issuance, exercisability, vesting and/or ability to retain any award; (v) to prescribe and amend the terms of the agreements or
other documents evidencing awards made under this Plan (which need not be identical) and the terms of or form of any document or notice
required to be delivered to the Company by grantees under this Plan; (vi) to determine the extent to which adjustments are required pursuant
to Article One; (vii) to interpret and construe this Plan, any rules and regulations under this Plan and the terms and conditions of any
award granted hereunder, and to make exceptions to any such provisions for the benefit of the Company; (viii) to approve corrections in
the documentation or administration of any award; and (ix) to make all other determinations deemed necessary or advisable for the administration
of this Plan.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify"></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">C.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>All decisions, determinations and interpretations by the Committee regarding the Plan, any rules and regulations under the
Plan and the terms and conditions of or operation of any award granted hereunder, shall be final and binding on all grantees, beneficiaries,
heirs, assigns or other persons holding or claiming rights under the Plan or any award. The Committee shall consider such factors as it
deems relevant, in its sole and absolute discretion, to making such decisions, determinations and interpretations including, without limitation,
the recommendations or advice of any officer or other employee of the Company and such attorneys, consultants and accountants as it may
select.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">D.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Committee may delegate all or a portion of their duties hereunder to one or more individuals or committees. Any reference
to the Committee or the Plan Administrator shall refer to such individual(s) or committee(s) to the extent of such delegation.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: windowtext">IV.</FONT></TD><TD STYLE="text-align: justify">ELIGIBILITY</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">A.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The persons eligible to participate in the Discretionary Option Grant and Stock Issuance Programs shall be limited to the
following:</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in"><FONT STYLE="color: windowtext">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>officers and other employees of the Company (or its parent or subsidiary corporations);</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in"><FONT STYLE="color: windowtext">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>individuals who are consultants or independent advisors and who provide valuable services to the Company (or its parent
or subsidiary corporations); and</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in"><FONT STYLE="color: windowtext">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>non-employee members of the Board (or of the board of directors of parent or subsidiary corporations), subject to the limits
set forth in Section II.A. of Article Four.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">B.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Only Board members who are not employees of the Company (or any parent or subsidiary) shall be eligible to receive grants
pursuant to the Director Grant Program specified in Article Four.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">C.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Plan Administrator shall, within the scope of its administrative jurisdiction under the Plan, have full power and authority
to determine (i) whether to grant options in accordance with the Discretionary Option Grant Program or to effect stock issuances in accordance
with the Stock Issuance Program, (ii) which eligible persons are to receive option grants under the Discretionary Option Grant Program,
the time or times when such option grants are to be made, the number of shares to be covered by each such grant, the status of the granted
option as either an incentive stock option (&ldquo;Incentive Option&rdquo;) which satisfies the requirements of Section 422 of the Internal
Revenue Code of 1986, as amended (the &ldquo;Code&rdquo;) or a non-statutory option not intended to meet such requirements, the time or
times when each such option is to become exercisable, the vesting schedule (if any) applicable to the option shares and the maximum term
for which such option is to remain outstanding, and (iii) which eligible persons are to receive stock issuances under the Stock Issuance
Program, the time or times when such issuances are to be made, the number of shares to be issued to each grantee, the vesting schedule
(if any) applicable to the shares and the consideration for such shares.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: windowtext">V.</FONT></TD><TD STYLE="text-align: justify">STOCK SUBJECT TO THE PLAN</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">A.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Shares of the Company&rsquo;s Common Stock shall be available for issuance under the Plan and shall be drawn from either
the Company&rsquo;s authorized but unissued shares of Common Stock or from reacquired shares of Common Stock, including shares repurchased
by the Company on the open market. The maximum number of shares of Common Stock which may be issued over the term of the Plan, as amended
and restated, shall not exceed 81,090,000 shares, subject to adjustment from time to time in accordance with the provisions of this Section
V. The total number of shares available under the Plan, as amended and restated, as of April 21, 2025 is 60,095,997. This amount consists
of 46,884,625 shares reserved for awards already issued, 2,211,372 shares of Common Stock available for future issuance under the Plan,
and the increase of 11,000,000 shares of Common Stock authorized by the Board (subject to approval by the Company&rsquo;s stockholders
at the Annual Meeting of Stockholders on June 12, 2025).</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">B.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>In no event shall the number of shares of Common Stock for which any one individual participating in the Plan may receive
options, separately exercisable stock appreciation rights and direct stock issuances and RSUs exceed 1,500,000 shares of Common Stock
in the aggregate in any calendar year. For purposes of such limitation, however, no stock options granted prior to the date the Common
Stock was first registered under Section 12 of the 1934 Act (the &ldquo;Section 12(g) Registration Date&rdquo;) shall be taken into account.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">C.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Should an outstanding option under this Plan expire or terminate for any reason prior to exercise in full, the shares subject
to the portion of the option not so exercised shall be available for subsequent option grants or direct stock issuances or RSUs under
the Plan. Unvested shares issued under the Plan and subsequently repurchased by the Company, at the original issue price paid per share,
pursuant to the Company&rsquo;s repurchase rights under the Plan, or shares underlying terminated RSUs, shall be added back to the number
of shares of Common Stock reserved for issuance under the Plan and shall accordingly be available for reissuance through one or more subsequent
option grants or direct stock issuances or RSUs under the Plan. However, shares subject to an award under the Plan may not again be made
available for issuance under the Plan if such shares are: (i) shares that were subject to a stock-settled stock appreciation right and
were not issued upon the net settlement or net exercise of such stock appreciation right, (ii) shares used to pay the exercise price of
an option, (iii) shares delivered to or withheld by the Company to pay the withholding taxes related to an award, or (iv) shares repurchased
on the open market with the proceeds of an option exercise. Shares of Common Stock subject to any option surrendered for an appreciation
distribution under Section IV of Article Two or Section II.B.1.(iv) of Article Four shall not be available for subsequent issuance under
the Plan.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">D.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>In the event any change is made to the Common Stock issuable under the Plan by reason of any stock split, stock dividend,
recapitalization, combination of shares, exchange of shares or other change affecting the outstanding Common Stock as a class without
receipt of consideration, then appropriate adjustments shall be made to (i) the maximum number and/or class of securities issuable under
the Plan, (ii) the maximum number and/or class of securities for which any one individual participating in the Plan may be granted stock
options, separately exercisable stock appreciation rights, and direct stock issuances and RSUs under the Plan from and after the Section
12(g) Registration Date, (iii) the number and/or class of securities and price per share in effect under each outstanding option and stock
appreciation right under the Plan, (iv) the number and/or class of securities in effect under each outstanding direct stock issuance and
RSU under the Plan, and (v) the number and/or class of securities for which grants are subsequently to be made per non-employee Board
member under the Director Grant Program. The purpose of such adjustments shall be to preclude the enlargement or dilution of rights and
benefits under the Plan.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">E.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The fair market value per share of Common Stock on any relevant date under the Plan shall be determined in accordance with
the following provisions:</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in"><FONT STYLE="color: windowtext">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>If the Common Stock is not at the time listed or admitted to trading on any national securities exchange but is traded in
the over-the-counter market, the fair market value shall be the mean between the highest bid and lowest asked prices (or, if such information
is available, the closing selling price) per share of Common Stock on the date in question in the over-the-counter market, as such prices
are reported on the Nasdaq National Market, the Nasdaq Global Select Market or any successor system. If there are no reported bid and
asked prices (or closing selling price) for the Common Stock on the date in question, then the mean between the highest bid price and
lowest asked price (or the closing selling price) on the last preceding date for which such quotations exist shall be determinative of
fair market value.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in"><FONT STYLE="color: windowtext">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>If the Common Stock is at the time listed or admitted to trading on any national securities exchange, then the fair market
value shall be the closing selling price per share of Common Stock on the date in question on the securities exchange determined by the
Plan Administrator to be the primary market for the Common Stock, as such price is officially quoted in the composite tape of transactions
on such exchange. If there is no reported sale of Common Stock on the exchange on the date in question, then the fair market value shall
be the closing selling price on the exchange on the last preceding date for which such quotation exists.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in"><FONT STYLE="color: windowtext">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>If the Common Stock is at the time neither listed nor admitted to trading on any securities exchange nor traded in the over-the-counter
market, then the fair market value shall be determined by the Plan Administrator after taking into account such factors as the Plan Administrator
shall deem appropriate.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: windowtext">VI.</FONT></TD><TD STYLE="text-align: justify">MINIMUM VESTING</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Notwithstanding any other provision of this Plan to the
contrary, in no event shall any award granted pursuant to this Plan vest prior to the twelve (12)-month anniversary of the date of grant,
other than in connection with the grantee&rsquo;s death or permanent disability or, to the extent permitted hereunder, in connection with
a Change in Control (provided that this limitation shall not apply with respect to up to five percent (5%) of the shares of Common Stock
available for issuance under this Plan following approval of the Plan at the Company&rsquo;s Annual Meeting of Stockholders on June 12,
2025). The minimum vesting period set forth in this Section VI may not be waived or superseded by any provision in an award or other agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="color: windowtext">ARTICLE
Two</FONT><U><BR>
DISCRETIONARY OPTION GRANT PROGRAM</U></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: windowtext">I.</FONT></TD><TD STYLE="text-align: justify">TERMS AND CONDITIONS OF OPTIONS</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Options granted pursuant to this Article Two shall be
authorized by action of the Plan Administrator and may, at the Plan Administrator&rsquo;s discretion, be either Incentive Options or non-statutory
options. Individuals who are not Employees may only be granted non-statutory options under this Article Two. Each option granted shall
be evidenced by one or more instruments in the form approved by the Plan Administrator. Each such instrument shall, however, comply with
the terms and conditions specified below, and each instrument evidencing an Incentive Option shall, in addition, be subject to the applicable
provisions of Section II of this Article Two.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">A.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><B><U>Option Price</U></B>.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="color: windowtext">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The option price per share shall be fixed by the Plan Administrator. In no event, however, shall the option price per share
be less than one hundred percent (100%) of the fair market value per share of Common Stock on the date of the option grant.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="color: windowtext">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The option price shall become immediately due upon exercise of the option and shall, subject to the provisions of Section
IV of this Article Two and the instrument evidencing the grant, be payable through one of the following methods (or a combination thereof):</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in"><FONT STYLE="color: windowtext">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>full payment in cash or check drawn to the Company&rsquo;s order;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in"><FONT STYLE="color: windowtext">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>full payment in shares of Common Stock held by the optionee for the requisite period necessary to avoid a charge to the
Company&rsquo;s earnings for financial reporting purposes and valued at fair market value on the Exercise Date (as such term is defined
below);</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in"><FONT STYLE="color: windowtext">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>full payment through a &ldquo;net settlement&rdquo; procedure pursuant to which the Company shall withhold shares of Common
Stock issuable in connection with the exercise of the option with a fair market value equal to the exercise price and, if elected by the
optionee, all applicable Federal and State income and employment taxes required to be withheld by the Company in connection with such
exercise;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in"><FONT STYLE="color: windowtext">(iv)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>full payment through a broker-dealer sale and remittance procedure pursuant to which the optionee (I) shall provide irrevocable
written instructions to a designated brokerage firm to effect the immediate sale of the purchased shares and remit to the Company, out
of the sale proceeds available on the settlement date, sufficient funds to cover the aggregate option price payable for the purchased
shares plus all applicable Federal and State income and employment taxes required to be withheld by the Company in connection with such
purchase and (II) shall provide written directives to the Company to deliver the certificates for the purchased shares directly to such
brokerage firm in order to complete the sale transaction; or</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in">&nbsp;</P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in"><FONT STYLE="color: windowtext">(v)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>such other method as permitted by the Plan Administrator, including any combination of the foregoing.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">For purposes of this subparagraph 2, the Exercise Date
shall be the date on which written notice of the option exercise is delivered to the Company. Except to the extent the sale and remittance
procedure is utilized in connection with the exercise of the option, payment of the option price for the purchased shares must accompany
such notice.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">B.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><B><U>Term and Exercise of Options</U></B>.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1.5in; margin: 0pt 0">Each option granted under this Article Two shall be
exercisable at such time or times, during such period, and for such number of shares as shall be determined by the Plan Administrator
and set forth in the instrument evidencing the option grant. No such option, however, shall have a maximum term in excess of ten (10)
years from the grant date. During the lifetime of the optionee, the option, together with any stock appreciation rights pertaining to
such option, shall be exercisable only by the optionee and shall not be assignable or transferable by the optionee except for a transfer
of the option by will or by the laws of descent and distribution following the optionee&rsquo;s death and, for the avoidance of doubt,
may not be transferred to a third party for cash or other value. However, the Plan Administrator shall have the discretion to provide
that a non-statutory option may, in connection with the optionee&rsquo;s estate plan, be assigned in whole or in part during the optionee&rsquo;s
lifetime either (i) as a gift to one or more members of optionee&rsquo;s immediate family, to a trust in which optionee and/or one or
more such family members hold more than fifty percent (50%) of the beneficial interest or an entity in which more than fifty percent (50%)
of the voting interests are owned by optionee and/or one or more such family members, or (ii) pursuant to a domestic relations order.
The assigned portion shall be exercisable only by the person or persons who acquire a proprietary interest in the option pursuant to such
assignment. The terms applicable to the assigned portion shall be the same as those in effect for this option immediately prior to such
assignment and shall be set forth in such documents issued to the assignee as the Plan Administrator may deem appropriate.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">C.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><B><U>Termination of Service</U></B>.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="color: windowtext">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Except to the extent otherwise provided pursuant to Section V of this Article Two or pursuant to an applicable award agreement,
the following provisions shall govern the exercise period applicable to any options held by the optionee at the time of cessation of Service
or death.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in"><FONT STYLE="color: windowtext">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Should the optionee cease to remain in Service for any reason other than death or permanent disability, then the period
for which each outstanding option held by such optionee is to remain exercisable shall be limited to the three (3)-month period following
the date of such cessation of Service. However, should optionee die during the three (3)-month period following his or her cessation of
Service, the personal representative of the optionee&rsquo;s estate or the person or persons to whom the option is transferred pursuant
to the optionee&rsquo;s will or in accordance with the laws of descent and distribution shall have a twelve (12)-month period following
the date of the optionee&rsquo;s death during which to exercise such option.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in">&nbsp;</P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in"><FONT STYLE="color: windowtext">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>In the event such Service terminates by reason of permanent disability (as defined in Section 22(e)(3) of the Code), then
the period for which each outstanding option held by the optionee is to remain exercisable shall be limited to the twelve (12)-month period
following the date of such cessation of Service.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in"><FONT STYLE="color: windowtext">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Should the optionee, after completing five (5) full years of Service, die while in Service, then the exercisability of each
of his or her outstanding options shall automatically accelerate so that each such option shall become fully exercisable with respect
to the total number of shares of Common Stock at the time subject to such option and may be exercised for all or any portion of such shares.
The personal representative of the optionee&rsquo;s estate or the person or persons to whom the option is transferred pursuant to the
optionee&rsquo;s will or in accordance with the laws of descent and distribution shall have a twelve (12)-month period following the date
of the optionee&rsquo;s death during which to exercise such option.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in"><FONT STYLE="color: windowtext">(iv)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>In the event such Service terminates by reason of death prior to the optionee obtaining five (5) full years of Service,
then the period for which each outstanding vested option held by the optionee at the time of death shall be exercisable by the optionee&rsquo;s
estate or the person or persons to whom the option is transferred pursuant to the optionee&rsquo;s will or in accordance with the laws
of descent and distribution shall be limited to the twelve (12)-month period following the date of the optionee&rsquo;s death.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in"><FONT STYLE="color: windowtext">(v)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Under no circumstances, however, shall any such option be exercisable after the specified expiration date of the option
term.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in"><FONT STYLE="color: windowtext">(vi)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Each such option shall, during such limited exercise period, be exercisable for any or all of the shares for which the option
is exercisable on the date of the optionee&rsquo;s cessation of Service. Upon the expiration of such limited exercise period or (if earlier)
upon the expiration of the option term, the option shall terminate and cease to be exercisable. However, each outstanding option shall
immediately terminate and cease to remain outstanding, at the time of the optionee&rsquo;s cessation of Service, with respect to any shares
for which the option is not otherwise at that time exercisable or in which the optionee is not otherwise vested.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in"><FONT STYLE="color: windowtext">(vii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Should (i) the optionee&rsquo;s Service be terminated for misconduct (including, but not limited to, any act of dishonesty,
willful misconduct, fraud or embezzlement) or (ii) the optionee make any unauthorized use or disclosure of confidential information or
trade secrets of the Company or its parent or subsidiary corporations, then in any such event all outstanding options held by the optionee
under this Article Two shall terminate immediately and cease to be exercisable.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="color: windowtext">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Plan Administrator shall have complete discretion, exercisable either at the time the option is granted or at any time
while the option remains outstanding, to permit one or more options held by the optionee under this Article Two to be exercised, during
the limited period of exercisability provided under subparagraph 1 above, not only with respect to the number of shares for which each
such option is exercisable at the time of the optionee&rsquo;s cessation of Service but also with respect to one or more subsequent installments
of purchasable shares for which the option would otherwise have become exercisable had such cessation of Service not occurred.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="color: windowtext">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>For purposes of the foregoing provisions of this Section I.C (and for all other purposes under the Plan):</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in"><FONT STYLE="color: windowtext">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The optionee shall be deemed to remain in the <B>Service</B> of the Company for so long as such individual renders services
on a periodic basis to the Company (or any parent or subsidiary corporation) in the capacity of an Employee, a non-employee member of
the board of directors or an independent consultant or advisor, unless the agreement evidencing the applicable option grant specifically
states otherwise.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in"><FONT STYLE="color: windowtext">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The optionee shall be considered to be an <B>Employee </B>for so long as such individual remains in the employ of the Company
or one or more of its parent or subsidiary corporations, subject to the control and direction of the employer entity not only as to the
work to be performed but also as to the manner and method of performance.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">D.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><B><U>Stockholder Rights</U></B>.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1.5in; margin: 0pt 0">An optionee shall have no stockholder rights with respect
to any shares covered by the option until such individual shall have exercised the option and paid the option price for the purchased
shares. Without limitation, an optionee shall not have any right to receive dividends with respect to an unexercised option.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">E.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><B><U>No Repricing</U></B>.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1.5in; margin: 0pt 0">No option or stock appreciation right may be repriced,
regranted through cancellation, including cancellation in exchange for cash or other awards, or otherwise amended to reduce its option
price or exercise price (other than with respect to adjustments made in connection with a transaction or other change in the Company&rsquo;s
capitalization as permitted under this Plan) without the approval of the stockholders of the Company.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">F.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><B><U>Repurchase Rights</U></B>.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1.5in; margin: 0pt 0">The shares of Common Stock acquired upon the exercise
of options granted under this Article Two may be subject to repurchase by the Company in accordance with the following provisions:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="color: windowtext">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Plan Administrator shall have the discretion to grant options which are exercisable for unvested shares of Common Stock
under this Article Two. Should the optionee cease Service while holding such unvested shares, the Company shall have the right to repurchase
any or all those unvested shares at the option price paid per share. The terms and conditions upon which such repurchase right shall be
exercisable (including the period and procedure for exercise and the appropriate vesting schedule for the purchased shares) shall be established
by the Plan Administrator and set forth in the instrument evidencing such repurchase right.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="color: windowtext">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>All of the Company&rsquo;s outstanding repurchase rights shall automatically terminate, and all shares subject to such terminated
rights shall immediately vest in full, upon the occurrence of any Corporate Transaction under Section III of this Article Two, except
to the extent: (i) any such repurchase right is expressly assigned to the successor corporation (or parent thereof) in connection with
the Corporate Transaction or (ii) such termination is precluded by other limitations imposed by the Plan Administrator at the time the
repurchase right is issued.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="color: windowtext">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Plan Administrator shall have the discretionary authority, exercisable either before or after the optionee&rsquo;s cessation
of Service, to cancel the Company&rsquo;s outstanding repurchase rights with respect to one or more shares purchased or purchasable by
the optionee under this Discretionary Option Grant Program and thereby accelerate the vesting of such shares in whole or in part at any
time.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: windowtext">II.</FONT></TD><TD STYLE="text-align: justify">INCENTIVE OPTIONS</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">The terms and conditions specified below shall be applicable
to all Incentive Options granted under this Article Two. Incentive Options may only be granted to individuals who are Employees of the
Company. Options which are specifically designated as &ldquo;non-statutory&rdquo; options when issued under the Plan shall not be subject
to such terms and conditions.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">A.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><B><U>Dollar Limitation</U></B>. The aggregate fair market value (determined as of the respective date or dates of grant)
of the Common Stock for which one or more options granted to any Employee under this Plan (or any other option plan of the Company or
its parent or subsidiary corporations) may for the first time become exercisable as incentive stock options under the Federal tax laws
during any one calendar year shall not exceed the sum of One Hundred Thousand Dollars ($100,000). To the extent the Employee holds two
or more such options which become exercisable for the first time in the same calendar year, the foregoing limitation on the exercisability
of such options as incentive stock options under the Federal tax laws shall be applied on the basis of the order in which such options
are granted. Should the number of shares of Common Stock for which any Incentive Option first becomes exercisable in any calendar year
exceed the applicable One Hundred Thousand Dollar ($100,000) limitation, then that option may nevertheless be exercised in such calendar
year for the excess number of shares as a non-statutory option under the Federal tax laws.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">B.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><B><U>10% Stockholder</U></B>. If any individual to whom an Incentive Option is granted is the owner of stock (as determined
under Section 424(d) of the Code) possessing 10% or more of the total combined voting power of all classes of stock of the Company or
any one of its parent or subsidiary corporations, then the option price per share shall not be less than one hundred and ten percent (110%)
of the fair market value per share of Common Stock on the grant date, and the option term shall not exceed five (5) years, measured from
the grant date.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">C.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><B><U>Termination of Employment</U></B>. Any portion of an Incentive Option that remains outstanding (by reason of the optionee
remaining in the Service of the Company, pursuant to the Plan Administrator&rsquo;s exercise of discretion under Section V of this Article
Two, or otherwise) more than 3 months following the date an optionee ceases to be an Employee of the Company shall thereafter be exercisable
as a non-statutory option under federal tax laws.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Except as modified by the preceding provisions of this
Section II, the provisions of Articles One, Two and Five of the Plan shall apply to all Incentive Options granted hereunder.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: windowtext">III.</FONT></TD><TD STYLE="text-align: justify">CORPORATE TRANSACTIONS/CHANGES IN CONTROL</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">A.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>For purposes of this Section III (and for all other purposes under the Plan), a Corporate Transaction shall be deemed to
occur in the event of:</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="color: windowtext">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>a merger or consolidation in which the Company is not the surviving entity, except for a transaction the principal purpose
of which is to change the State of the Company&rsquo;s incorporation,</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="color: windowtext">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>the sale, transfer or other disposition of all or substantially all of the assets of the Company in liquidation or dissolution
of the Company, or</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="color: windowtext">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any reverse merger in which the Company is the surviving entity but in which securities possessing more than fifty percent
(50%) of the total combined voting power of the Company&rsquo;s outstanding securities are transferred to a person or persons different
from the persons holding those securities immediately prior to such merger.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">B.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Immediately after the consummation of the Corporate Transaction, all outstanding options under this Article Two shall fully
vest, terminate and cease to be outstanding, except to the extent continued or assumed (as applicable) by the Company or the successor
corporation or its parent company. The Plan Administrator shall have complete discretion to provide, on such terms and conditions as it
sees fit, for a cash payment to be made to any optionee on account of any option terminated in accordance with this paragraph, in an amount
equal to the excess (if any) of (A) the fair market value of the shares subject to the option as of the date of the Corporate Transaction,
over (B) the aggregate exercise price of the option.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">C.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Each outstanding option under this Article Two which is assumed in connection with the Corporate Transaction or is otherwise
to continue in effect shall be appropriately adjusted, immediately after such Corporate Transaction, to apply and pertain to the number
and class of securities which would have been issued to the option holder, in consummation of such Corporate Transaction, had such person
exercised the option immediately prior to such Corporate Transaction. Appropriate adjustments shall also be made to the option price payable
per share, <U>provided</U> the aggregate option price payable for such securities shall remain the same. In addition, the class and number
of securities available for issuance under the Plan following the consummation of the Corporate Transaction shall be appropriately adjusted.
Any such options that are so continued or assumed in connection with a Corporate Transaction shall be treated as follows: if the grantee&rsquo;s
employment is terminated by the Company without Cause or the grantee resigns due to a Constructive Termination, in either case within
the ninety (90) day period preceding or the two (2) year period following the Corporate Transaction, the exercisability of such option
shall automatically accelerate, and the Company&rsquo;s outstanding repurchase rights under this Article Two shall immediately terminate;
provided, however, that if the Company, the acquiror or successor refuses to continue (or, as applicable, assume) the option in connection
with the Corporate Transaction, the exercisability of such option under this Article Two shall automatically accelerate, and the Company&rsquo;s
outstanding repurchase rights under this Article Two shall immediately terminate upon the occurrence of such Corporate Transaction.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">D.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The grant of options under this Article Two shall in no way affect the right of the Company to adjust, reclassify, reorganize
or otherwise change its capital or business structure or to merge, consolidate, dissolve, liquidate or sell or transfer all or any part
of its business or assets.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">E.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>In the event of a Change in Control: if the grantee&rsquo;s employment is terminated by the Company without Cause or the
grantee resigns due to a Constructive Termination, in either case within the ninety (90) day period preceding or the two (2) year period
following the Change in Control, the exercisability of the grantee&rsquo;s options shall automatically accelerate, and the Company&rsquo;s
outstanding repurchase rights under this Article Two shall immediately terminate; provided, however, that if the acquiror or successor
refuses to assume the option in connection with the Change in Control, the exercisability of such option under this Article Two shall
automatically accelerate, and the Company&rsquo;s outstanding repurchase rights under this Article Two shall immediately terminate upon
the occurrence of such Change in Control. In the event that the acquiror or successor refuses to assume the option in connection with
the Change in Control, the Plan Administrator shall have complete discretion to provide, on such terms and conditions as it sees fit,
for a cash payment to be made to any optionee on account of any option terminated in accordance with this paragraph, in an amount equal
to the excess (if any) of (A) the fair market value of the shares subject to the option as of the date of the Change in Control, over
(B) the aggregate exercise price of the option.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">F.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>For purposes of this Section III (and for all other purposes under the Plan), a Change in Control shall be deemed to occur
in the event:</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="color: windowtext">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any person or related group of persons (other than the Company or a person that directly or indirectly controls, is controlled
by, or is under common control with, the Company) directly or indirectly acquires beneficial ownership (within the meaning of Rule 13d-3
of the 1934 Act) of securities possessing more than fifty percent (50%) of the total combined voting power of the Company&rsquo;s outstanding
securities pursuant to a tender or exchange offer made directly to the Company&rsquo;s stockholders; or</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="color: windowtext">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>there is a change in the composition of the Board over a period of twenty-four (24) consecutive months or less such that
a majority of the Board members (rounded up to the next whole number) ceases, by reason of one or more contested elections for Board membership,
to be comprised of individuals who either (A) have been Board members continuously since the beginning of such period or (B) have been
elected or nominated for election as Board members during such period by at least two-thirds of the Board members described in clause
(A) who were still in office at the time such election or nomination was approved by the Board.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">G.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Unless terminated in accordance with Section III.B of this Article Two above, all options accelerated in connection with
the Corporate Transaction or Change in Control (either at the time of the Corporate Transaction or Change in Control or as otherwise provided
in this Section III) shall remain fully exercisable until the expiration or sooner termination of the option term.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">H.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The portion of any Incentive Option accelerated under this Section III in connection with a Corporate Transaction or Change
in Control shall remain exercisable as an incentive stock option under the Federal tax laws only to the extent the dollar limitation of
Section II of this Article Two is not exceeded. To the extent such dollar limitation is exceeded, the accelerated portion of such option
shall be exercisable as a non-statutory option under the Federal tax laws.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">I.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>For purposes of this Article Two and for purposes of Article Three:</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="color: windowtext">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>&ldquo;Cause&rdquo; means, unless otherwise provided in the applicable award agreement, the Company&rsquo;s termination
of the grantee&rsquo;s employment for any of the following reasons: (i) failure or refusal to comply in any material respect with lawful
policies, standards or regulations of the Company; (ii) a violation of a federal or state law or regulation applicable to the business
of the Company; (iii) conviction or plea of no contest to a felony under the laws of the United States or any State; (iv) fraud or misappropriation
of property belonging to the Company or its affiliates; (v) a breach in any material respect of the terms of any confidentiality, invention
assignment or proprietary information agreement with the Company or with a former employer; (vi) failure to satisfactorily perform the
grantee&rsquo;s duties after having received written notice of such failure and at least thirty (30) days to cure such failure; or (vii)
misconduct or gross negligence in connection with the performance of the grantee&rsquo;s duties.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="color: windowtext">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>&ldquo;Constructive Termination&rdquo; means, unless otherwise provided in the applicable award agreement, the grantee&rsquo;s
resignation of employment with the Company within ninety (90) days of the occurrence of any of the following: (i) a material reduction
in the grantee&rsquo;s responsibilities; (ii) a material reduction in the grantee&rsquo;s base salary; or (iii) a relocation of the grantee&rsquo;s
principal office to a location more than 50 miles from the location of the grantee&rsquo;s existing principal office.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: windowtext">IV.</FONT></TD><TD STYLE="text-align: justify">STOCK APPRECIATION RIGHTS</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">A.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Provided and only if the Plan Administrator determines in its discretion to implement the stock appreciation right provisions
of this Section IV, one or more optionees may be granted the right, exercisable upon such terms and conditions as the Plan Administrator
may establish, to surrender all or part of an unexercised option granted under this Article Two in exchange for a distribution from the
Company in an amount equal to the excess of (i) the fair market value (on the option surrender date) of the number of shares in which
the optionee is at the time vested under the surrendered option (or surrendered portion thereof) over (ii) the aggregate option price
payable for such vested shares. The distribution may be made in shares of Common Stock valued at fair market value on the option surrender
date, in cash, or partly in shares and partly in cash, as the Plan Administrator shall determine in its sole discretion.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">B.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The shares of Common Stock subject to any option surrendered for an appreciation distribution pursuant to this Section IV
shall not be available for subsequent option grant under the Plan.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">C.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><B><U>Stockholder Rights</U></B>. A stock appreciation right holder shall have no stockholder rights with respect to any
shares covered by the stock appreciation right until such individual shall have exercised the stock appreciation right and received the
acquired shares. Without limitation, a stock appreciation right holder shall not have any right to receive dividends with respect to a
stock appreciation right.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: windowtext">V.</FONT></TD><TD STYLE="text-align: justify">EXTENSION OF EXERCISE PERIOD</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">The Plan Administrator shall have full power and authority,
exercisable either at the time the option is granted or at any time while the option remains outstanding, to extend the period of time
for which any option granted under this Article Two is to remain exercisable following the optionee&rsquo;s cessation of Service or death
from the limited period in effect under Section I.C.1 of Article Two to such greater period of time as the Plan Administrator shall deem
appropriate; <U>provided</U>, however, that in no event shall such option be exercisable after the specified expiration date of the option
term.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="color: windowtext">ARTICLE
Three</FONT><U><BR>
STOCK ISSUANCE PROGRAM</U></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: windowtext">I.</FONT></TD><TD STYLE="text-align: justify">STOCK ISSUANCE TERMS</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Shares of Common Stock may be issued under the Stock
Issuance Program through direct and immediate issuances without any intervening option grants. Each such stock issuance shall be evidenced
by a Stock Issuance Agreement which complies with the terms specified below. Shares of Common Stock may also be issued under the Stock
Issuance Program pursuant to RSUs, which are awards granted to eligible individuals that entitle them to shares of Common Stock (or cash
in lieu thereof) in the future following the satisfaction of vesting conditions imposed by the Plan Administrator.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">A.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><B><U>Vesting Provisions</U></B>.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="color: windowtext">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Plan Administrator may issue shares of Common Stock under the Stock Issuance Program which are to vest in one or more
installments over the grantee&rsquo;s period of Service or upon attainment of specified performance objectives. Alternatively, the Plan
Administrator may issue RSUs under the Stock Issuance Program which shall entitle the recipient to receive a specified number of shares
of Common Stock upon the attainment of one or more Service and/or performance goals established by the Plan Administrator. Upon the attainment
of such Service and/or performance goals, fully-vested shares of Common Stock shall be issued in satisfaction of those RSUs.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="color: windowtext">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Any new, substituted or additional securities or other property (including money paid other than as a regular cash dividend)
issued by reason of any stock dividend, stock split, recapitalization, combination of shares, exchange of shares or other change affecting
the outstanding Common Stock as a class without the Company&rsquo;s receipt of consideration, shall be issued or set aside with respect
to the shares of unvested Common Stock granted to a grantee or subject to a grantee&rsquo;s RSUs, subject to (i) the same vesting requirements
applicable to the grantee&rsquo;s unvested shares of Common Stock or RSUs, and (ii) such escrow arrangements as the Plan Administrator
shall deem appropriate.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="color: windowtext">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The grantee shall have full stockholder rights with respect to any shares of Common Stock issued to the grantee under the
Stock Issuance Program, whether or not the grantee&rsquo;s interest in those shares is vested, except that the grantee shall not have
dividend rights with respect to such shares prior to the vesting of such shares. However, the Plan Administrator may provide for a grantee
to receive one or more dividend equivalents with respect to such shares, entitling the grantee to all regular cash dividends payable on
such shares of Common Stock, which amounts shall be (i) subject to the same vesting requirements applicable to the shares of Common Stock
granted hereunder, and (ii) payable upon vesting of the shares to which such dividend equivalents relate.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="color: windowtext">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The grantee shall not have any stockholder rights with respect to any shares of Common Stock subject to an RSU. However,
the Plan Administrator may provide for a grantee to receive one or more dividend equivalents with respect to such shares, entitling the
grantee to all regular cash dividends payable on the shares of Common Stock underlying the RSU, which amounts shall be (i) subject to
the same vesting requirements applicable to the shares of Common Stock underlying the RSU, and (ii) payable upon issuance of the shares
to which such dividend equivalents relate.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="color: windowtext">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Should the grantee cease to remain in Service while holding one or more unvested shares of Common Stock issued under the
Stock Issuance Program or should the performance objectives not be attained with respect to one or more such unvested shares of Common
Stock, then those shares shall be immediately surrendered to the Company for cancellation, and the grantee shall have no further stockholder
rights with respect to those shares. To the extent the surrendered shares were previously issued to the grantee for consideration paid
in cash, the Company shall repay to the grantee the cash consideration paid for the surrendered shares.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="color: windowtext">6.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Except as prohibited by the last sentence of Section VI of Article One, the Plan Administrator may in its discretion waive
the surrender and cancellation of one or more unvested shares of Common Stock which would otherwise occur upon the cessation of the grantee&rsquo;s
Service or the non-attainment of the performance objectives applicable to those shares. Such waiver shall result in the immediate vesting
of the grantee&rsquo;s interest in the shares of Common Stock as to which the waiver applies. Such waiver may be effected at any time,
whether before or after the grantee&rsquo;s cessation of Service or the attainment or non-attainment of the applicable performance objectives.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="color: windowtext">7.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Outstanding RSUs under the Stock Issuance Program shall automatically terminate, and no shares of Common Stock shall actually
be issued in satisfaction of those awards, if the Service and/or performance goals established for such awards are not attained. The Plan
Administrator, however, shall, except as prohibited by the last sentence of Section VI of Article One above, have the discretionary authority
to issue shares of Common Stock in satisfaction of one or more outstanding RSUs as to which the designated Service and/or performance
goals are not attained. Such authority may be exercised at any time, whether before or after the grantee&rsquo;s cessation of Service
or the attainment or non-attainment of the applicable performance objectives.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: windowtext">II.</FONT></TD><TD STYLE="text-align: justify">CORPORATE TRANSACTION/CHANGE IN CONTROL</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">A.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>All of the Company&rsquo;s outstanding repurchase rights under the Stock Issuance Program shall terminate automatically,
and all the shares of Common Stock subject to those terminated rights shall immediately vest in full, in the event of any Corporate Transaction,
except to the extent (i) those repurchase rights are to be assigned to the successor corporation (or parent thereof) in connection with
such Corporate Transaction, or (ii) such accelerated vesting is precluded by other limitations imposed in the Stock Issuance Agreement,
unless the Plan Administrator determines to waive such limitations.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">B.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Each award which is assigned in connection with (or is otherwise to continue in effect after) a Corporate Transaction shall
be appropriately adjusted such that it shall apply and pertain to the number and class of securities issued to the grantee in consummation
of the Corporate Transaction with respect to the shares granted to grantee under this Article Three.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">C.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>In the event of a Change in Control, shares of restricted stock and RSUs shall be treated as follows: if the grantee&rsquo;s
employment is terminated by the Company without Cause or the grantee resigns due to a Constructive Termination, in either case within
the ninety (90) day period preceding or the two (2) year period following the Change in Control, the vesting of such restricted stock
and RSUs shall automatically accelerate (and all of the shares of Common Stock subject to such RSUs shall be issued to grantees), and
the Company&rsquo;s outstanding repurchase rights under this Article Three shall immediately terminate; provided, however, that if the
acquiror or successor refuses to assume the shares of restricted stock or RSUs or substitute an award of equivalent value (as determined
by the Committee in its discretion) in connection with the Change in Control, the vesting of such restricted stock or RSUs under this
Article Three shall automatically accelerate (and all of the shares of Common Stock subject to such RSUs shall be issued to grantees).
To the extent any shares of restricted stock or RSUs vest in whole or in part based on the achievement of performance criteria, the amount
that shall vest in accordance with the proviso to the immediately-preceding sentence shall vest based on the higher of actual performance
goal attainment through the date of the Change in Control or a prorated amount using target performance and based on the time elapsed
in the performance period as of the date of the Change in Control.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: windowtext">III.</FONT></TD><TD STYLE="text-align: justify">STOCKHOLDER RIGHTS</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">A.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Individuals who are granted shares of Common Stock pursuant to this Article Three shall be the owners of such shares for
all purposes while holding such Common Stock, and may exercise full voting rights with respect to those shares at all times while held
by the individuals. Individuals who have been granted RSUs shall have no voting rights with respect to Common Stock underlying RSUs unless
and until such Common Stock is reflected as issued and outstanding shares on the Company&rsquo;s stock ledger.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">B.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Individuals who are granted shares of Common Stock pursuant to this Article Three shall not have dividend rights with respect
to such shares prior to the vesting of such shares. However, the Plan Administrator may provide for a grantee to receive one or more dividend
equivalents with respect to such shares, entitling the grantee to all regular cash dividends payable on such shares of Common Stock, which
amounts shall be (i) subject to the same vesting requirements applicable to the shares of Common Stock granted hereunder, and (ii) payable
upon vesting of the shares to which such dividend equivalents relate.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: windowtext">IV.</FONT></TD><TD STYLE="text-align: justify">SHARE ESCROW / LEGENDS</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Unvested shares may, in the Plan Administrator&rsquo;s
discretion, be held in escrow by the Company until the grantee&rsquo;s interest in such shares vests or may be issued directly to the
grantee with restrictive legends on the certificates evidencing those unvested shares.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="color: windowtext">ARTICLE
Four</FONT><U><BR>
DIRECTOR GRANT PROGRAM</U></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: windowtext">I.</FONT></TD><TD STYLE="text-align: justify">ELIGIBILITY</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">The individuals eligible to receive grants pursuant to
the provisions of this Article Four shall be (i) those individuals who, after the effective date of this amendment and restatement, first
become non-employee Board members, whether through appointment by the Board, election by the Company&rsquo;s stockholders, or by continuing
to serve as a Board member after ceasing to be employed by the Company, and (ii) those individuals already serving as non-employee Board
members on the effective date of this amendment and restatement. As used herein, a &ldquo;non-employee&rdquo; Board member is any Board
member who is not employed by the Company on the date in question.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: windowtext">II.</FONT></TD><TD STYLE="text-align: justify">TERMS AND CONDITIONS OF DIRECTOR GRANTS</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">A.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><B><U>Grants</U></B>. Grants under this Article Four shall be made pursuant to a Director Compensation Policy adopted by
the Board (the &ldquo;Director Compensation Policy&rdquo;) and may be in the form of non-statutory options, RSUs, shares of Common Stock,
other awards issuable under the Plan or a combination thereof, as determined by the Committee. In no event shall the aggregate grant date
fair value (calculated in accordance with FASB ASC Topic 718) of all awards granted under the Plan during any calendar year to any non-employee
Board member (excluding any awards granted at the election of a non-employee Board member in lieu of all or any portion of cash retainers
or fees otherwise payable to non-employee Board members in cash), together with the amount of any cash fees or retainers paid to such
non-employee Board members during such calendar year with respect to such individual&rsquo;s service as a non-employee Board member, exceed
$750,000 (or, for a non-employee Board member who first joins the Board, $1,000,000).</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">B.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><B><U>Terms and Conditions of Grants</U></B>.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="color: windowtext">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><B><I><U>Options</U></I></B>.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in"><FONT STYLE="color: windowtext">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Term</U>. Each option granted under this Article Four shall be exercisable at such time or times, during such period,
and for such number of shares as shall be set forth in the Director Compensation Policy or as otherwise determined by the Plan Administrator
and set forth in the instrument evidencing the option grant. No such option, however, shall have a maximum term in excess of ten (10)
years from the grant date.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in">&nbsp;</P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in"><FONT STYLE="color: windowtext">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Option Price</U>. The option price per share shall be fixed by the Plan Administrator. In no event, however, shall the
option price per share be less than one hundred percent (100%) of the fair market value per share of Common Stock on the date of the option
grant. The option price shall become immediately due upon exercise of the option and shall, subject to Section II.B.1.(iv) of this Article
Four and the instrument evidencing the grant, be payable in any manner set forth in Section I.A.2 of Article Two.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in"><FONT STYLE="color: windowtext">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Non-Transferability</U>. During the lifetime of the optionee, each option grant, together with any limited stock appreciation
right pertaining to such option, shall be exercisable only by the optionee and shall not be assignable or transferable by the optionee,
except to the extent such option or the limited stock appreciation right is assigned or transferred (i) by will or by the laws of descent
and distribution following the optionee&rsquo;s death, or (ii) during optionee&rsquo;s lifetime either (A) as a gift in connection with
the optionee&rsquo;s estate plan to one or more members of optionee&rsquo;s immediate family, to a trust in which optionee and/or one
or more such family members hold more than fifty percent (50%) of the beneficial interest or to an entity in which more than fifty percent
(50%) of the voting interests are owned by optionee and/or one or more such family members, or (B) pursuant to a domestic relations order.
The portion of any option assigned or transferred during optionee&rsquo;s lifetime shall be exercisable only by the person or persons
who acquire a proprietary interest in the option pursuant to such assignment. The terms applicable to the assigned portion shall be the
same as those in effect for this option immediately prior to such assignment and shall be set forth in such documents issued to the assignee
as the Plan Administrator may deem appropriate.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in"><FONT STYLE="color: windowtext">(iv)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Stock Appreciation Rights</U>. With respect to each option granted under this Article Four, solely to the extent provided
by the Plan Administrator in its sole discretion, each optionee shall have the right to surrender all or part of the option (to the extent
not then exercised) in exchange for a distribution from the Company in an amount equal to the excess of (i) the fair market value (on
the option surrender date) of the number of shares in which the grantee is at the time vested under the surrendered option (or surrendered
portion thereof) over (ii) the aggregate option price payable for such vested shares. The distribution shall be made in shares of Common
Stock valued at fair market value on the option surrender date.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in"><FONT STYLE="color: windowtext">(v)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>No Repricing</U>. No option or stock appreciation right may be repriced, regranted through cancellation, including cancellation
in exchange for cash or other awards, or otherwise amended to reduce its option price or exercise price (other than with respect to adjustments
made in connection with a transaction or other change in the Company&rsquo;s capitalization as permitted under this Plan) without the
approval of the stockholders of the Company.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="color: windowtext">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><B><I><U>Grants Generally</U></I></B>.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in"><FONT STYLE="color: windowtext">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Stockholder Rights</U>. The holder of an option grant under this Article Four shall have none of the rights of a stockholder
with respect to any shares subject to such option until such individual shall have exercised the option and paid the exercise price for
the purchased shares, and the holder of RSUs granted under this Article Four shall have none of the rights of a stockholder with respect
to any shares subject to such RSUs until shares have been delivered in settlement thereof. Without limitation, a grantee shall not have
any right to receive dividends with respect to an unexercised option or unsettled RSUs.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in">&nbsp;</P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in"><FONT STYLE="color: windowtext">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Corporate Transactions/Changes in Control</U>. In connection with a Corporate Transaction or a Change in Control, grants
under this Article Four shall be treated in the manner specified in Article Two (with respect to options) or Article Three (with respect
to shares of Common Stock and RSUs), as applicable.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in"><FONT STYLE="color: windowtext">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Subject to the terms of the Plan, the terms and conditions of the grants under this Article Four shall be determined by
the Plan Administrator consistent with the Director Compensation Policy.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="color: windowtext">ARTICLE
Five</FONT><U><BR>
PERFORMANCE GOALS</U></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: windowtext">I.</FONT></TD><TD STYLE="text-align: justify">GENERAL</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">The Plan Administrator may establish performance criteria
and level of achievement versus such criteria that shall determine the number of shares of Common Stock or RSUs to be granted, retained,
vested, issued or issuable under or in settlement of or the amount payable pursuant to an award hereunder. In addition, the Plan Administrator
may specify that an award or a portion of an award shall be subject to measures based on one or more performance criteria selected by
the Committee and specified at the time the award is granted. The Committee shall certify the extent to which any performance criteria
have been satisfied, and the amount payable as a result thereof, prior to payment, settlement or vesting of any award subject thereto.
Notwithstanding satisfaction of any performance goals, the number of shares of Common Stock issued under or the amount paid under an award
may, to the extent specified in the applicable award agreement, be reduced by the Committee on the basis of such further considerations
as the Committee in its sole discretion shall determine.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: windowtext">II.</FONT></TD><TD STYLE="text-align: justify">PERFORMANCE CRITERIA</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">For purposes of this Plan, performance criteria may include
any one or more performance criteria, either individually, alternatively or in any combination, applied to either the Company as a whole
or to a business unit or subsidiary, either individually, alternatively or in any combination, and measured either quarterly, annually
or cumulatively over a period of years, on an absolute basis or relative to a pre-established target, to previous years&rsquo; results
or to a designated comparison group, in each case as specified by the Committee. The Committee (A) shall appropriately adjust any evaluation
of performance under applicable performance criteria to eliminate the effects of charges for restructurings, discontinued operations,
extraordinary items and all items of gain, loss or expense determined to be extraordinary or unusual in nature or related to the acquisition
or disposal of a segment of a business or related to a change in accounting principle all as determined in accordance with standards established
by opinion No. 30 of the Accounting Principles Board (APB Opinion No. 30) or other applicable or successor accounting provisions, as well
as the cumulative effect of accounting changes, in each case as determined in accordance with generally accepted accounting principles
or identified in the Company&rsquo;s financial statements or notes to the financial statements, and (B) may appropriately adjust any evaluation
of performance under applicable performance criteria to exclude any of the following events that occurs during a performance period: (i)
asset write-downs; (ii) litigation, claims, judgments or settlements; (iii) the effect of changes in tax law or other such laws or provisions
affecting reported results; (iv) the adverse effect of work stoppages or slowdowns; (v) accruals for reorganization and restructuring
programs; and (vi) accruals of any amounts for payment under this Plan or any other compensation arrangement maintained by the Company.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="color: windowtext">ARTICLE
Six</FONT><U><BR>
MISCELLANEOUS</U></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: windowtext">I.</FONT></TD><TD STYLE="text-align: justify">AMENDMENT OF THE PLAN</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">The Board shall have complete and exclusive power and
authority to amend or modify the Plan in any or all respects whatsoever. However, no such amendment or modification shall, without the
consent of the holders, adversely affect rights and obligations with respect to options at the time outstanding under the Plan. In addition,
certain amendments may require stockholder approval pursuant to applicable laws or regulations.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: windowtext">II.</FONT></TD><TD STYLE="text-align: justify">TAX WITHHOLDING</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">A.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company&rsquo;s obligation to deliver shares or cash upon the exercise of stock options or stock appreciation rights
or upon the grant or vesting of direct stock issuances or RSUs under the Plan shall be subject to the satisfaction of all applicable Federal,
State, and local income and employment tax withholding requirements.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">B.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Plan Administrator may, in its discretion and upon such terms and conditions as it may deem appropriate, provide any
or all holders of outstanding options or stock issuances under the Plan (other than the grants under Article Four) with the election to
have the Company withhold, from the shares of Common Stock otherwise issuable upon the exercise or vesting of such awards, a whole number
of such shares with an aggregate fair market value equal to the minimum amount necessary (or, if determined by the Plan Administrator
in its discretion and to the extent adverse accounting treatment does not result, at the maximum applicable individual statutory tax rates)
to satisfy the Federal, State and local income and employment tax withholdings (the &ldquo;Taxes&rdquo;) incurred in connection with the
acquisition or vesting of such shares. In lieu of such direct withholding, one or more grantees may also be granted the right to deliver
whole shares of Common Stock to the Company in satisfaction of such Taxes. Any withheld or delivered shares shall be valued at their fair
market value on the applicable determination date for such Taxes.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: windowtext">III.</FONT></TD><TD STYLE="text-align: justify">EFFECTIVE DATE AND TERM OF PLAN</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">A.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Plan, as amended and restated, shall be effective on the date specified in the Board of Directors resolution adopting
the Plan. Except as provided below, each option issued and outstanding under the Plan immediately prior to such effective date shall continue
to be governed solely by the terms and conditions of the agreement evidencing such grant, and nothing in this restatement of the Plan
shall be deemed to affect or otherwise modify the rights or obligations of the holders of such options with respect to their acquisition
of shares of Common Stock thereunder. The Plan Administrator shall, however, have full power and authority, under such circumstances as
the Plan Administrator may deem appropriate (but in accordance with Section I of this Article Five), to extend one or more features of
this amendment and restatement to any options outstanding on the effective date.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">B.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Unless sooner terminated in accordance with the other provisions of this Plan, the Plan shall terminate upon the <U>earlier</U>
of (i) ten (10) years following the date this amendment and restatement of the Plan is approved by the Board or (ii) the date on which
all shares available for issuance under the Plan shall have been issued or cancelled pursuant to the exercise, surrender or cash-out of
the options granted hereunder. If the date of termination is determined under clause (i) above, then any options or stock issuances outstanding
on such date shall continue to have force and effect in accordance with the provisions of the agreements evidencing those awards.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">C.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Options may be granted with respect to a number of shares of Common Stock in excess of the number of shares at the time
available for issuance under the Plan, <U>provided</U> each granted option is not to become exercisable, in whole or in part, at any time
prior to stockholder approval of an amendment authorizing a sufficient increase in the number of shares issuable under the Plan.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: windowtext">IV.</FONT></TD><TD STYLE="text-align: justify">USE OF PROCEEDS</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Any cash proceeds received by the Company from the sale
of shares pursuant to options or stock issuances granted under the Plan shall be used for general corporate purposes.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: windowtext">V.</FONT></TD><TD STYLE="text-align: justify">REGULATORY APPROVALS</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">A.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The implementation of the Plan, the granting of any option hereunder, and the issuance of stock (i) upon the exercise or
surrender of any option or (ii) under the Stock Issuance Program shall be subject to the procurement by the Company of all approvals and
permits required by regulatory authorities having jurisdiction over the Plan, the options granted under it and the stock issued pursuant
to it.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">B.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>No shares of Common Stock or other assets shall be issued or delivered under the Plan unless and until there shall have
been compliance with all applicable requirements of Federal and state securities laws, including (to the extent required) the filing and
effectiveness of the Form S-8 registration statement for the shares of Common Stock issuable under the Plan, and all applicable listing
requirements of any stock exchange (or the Nasdaq National Market, the Nasdaq Global Select Market or any successor system, if applicable)
on which the Common Stock is then trading.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: windowtext">VI.</FONT></TD><TD STYLE="text-align: justify">NO EMPLOYMENT/SERVICE RIGHTS</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Neither the action of the Company in establishing or
restating the Plan, nor any action taken by the Plan Administrator hereunder, nor any provision of the Plan shall be construed so as to
grant any individual the right to remain in the employ or service of the Company (or any parent or subsidiary corporation) for any period
of specific duration, and the Company (or any parent or subsidiary corporation retaining the services of such individual) may terminate
such individual&rsquo;s employment or service at any time and for any reason, with or without cause.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: windowtext">VII.</FONT></TD><TD STYLE="text-align: justify">MISCELLANEOUS PROVISIONS</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">A.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Except to the extent otherwise expressly provided in the Plan, the right to acquire Common Stock or other awards under the
Plan may not be assigned, encumbered or otherwise transferred by any grantee.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">B.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Awards issued under the Plan shall be subject to any clawback policy of the Company as in effect from time-to-time. No recovery
of compensation under any such policy will be an event giving rise to a right to resign for &ldquo;good reason&rdquo; or be deemed a &ldquo;constructive
termination&rdquo; (or any similar term) as such terms are used in any agreement between any grantee and the Company.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">C.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The provisions of the Plan relating to the exercise of options and the issuance and/or vesting of shares shall be governed
by the laws of the State of Delaware without resort to that state&rsquo;s conflict-of-laws provisions, as such laws are applied to contracts
entered into and performed in such State.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">D.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Plan is intended to be an unfunded plan. Grantees are and shall at all times be general creditors of the Company with
respect to their awards. If the Committee or the Company chooses to set aside funds in a trust or otherwise for the payment of awards
under the Plan, such funds shall at all times be subject to the claims of the creditors of the Company in the event of its bankruptcy
or insolvency.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: windowtext">E.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><B><U>Awards to Non-U.S. Employees</U></B>. The Committee shall have the power and authority to determine which subsidiary
corporations shall be covered by this Plan and which employees outside the United States shall be eligible to participate in the Plan.
The Committee may adopt, amend, or rescind rules, procedures, or sub-plans relating to the operation and administration of the Plan to
accommodate the specific requirements of local laws, procedures, and practices. Without limiting the generality of the foregoing, the
Committee is specifically authorized to adopt rules, procedures, and sub-plans with provisions that limit or modify rights on death, disability,
or retirement or on termination of employment; available methods of exercise or settlement of an award; payment of income, social insurance
contributions and payroll taxes; the withholding procedures and handling of any stock certificates or other indicia of ownership which
vary with local requirements. The Committee may also adopt rules, procedures or sub-plans applicable to particular subsidiary corporations
or locations.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; text-align: center">22</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>bcrx-20250611.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /qkpo7xRiXgen8uJbHxcOaeHGbP9wpB0KZkxsGx8HUk6by8jdQDB6yBEZrL2keEL -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:bcrx="http://globenewswire.com/20250611" elementFormDefault="qualified" targetNamespace="http://globenewswire.com/20250611">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://globenewswire.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="bcrx-20250611_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="bcrx-20250611_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>bcrx-20250611_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>bcrx-20250611_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://globenewswire.com/role/Cover" xlink:href="bcrx-20250611.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://globenewswire.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jun. 11, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 11,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-23186<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BioCryst Pharmaceuticals, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000882796<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">62-1413174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">4505 Emperor Blvd.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Durham<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">27703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(919)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">859-1302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BCRX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="f8k_061625.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globenewswire.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>bcrx-20250611.xsd</File>
    <File>bcrx-20250611_lab.xml</File>
    <File>bcrx-20250611_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="f8k_061625.htm">f8k_061625.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "f8k_061625.htm": {
   "nsprefix": "bcrx",
   "nsuri": "http://globenewswire.com/20250611",
   "dts": {
    "schema": {
     "local": [
      "bcrx-20250611.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "bcrx-20250611_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bcrx-20250611_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "f8k_061625.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://globenewswire.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-11",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f8k_061625.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-11",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f8k_061625.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001171843-25-003910-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001171843-25-003910-xbrl.zip
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M-)@C7+,*+Z+)4G!46L6B87MDW\O@$'PE])!>DP.JE#\;A'AM.2T"_V#SCZ0
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M/_[D!31U&!!_B1]T:SS6J]/OT?)07AK#XA4>"_.6$<;3]0KCX9F!00BJ@/(
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MREW.5E_FMFN3,7_AU)WDNEY%]CVK'%>>K9I!*N'@EELH_BL71^N$8*/XNGV
M?L^0M<5S'7BXM3/WJ+%JUZ.818+9]Q_?!Y^&QV-8F-N%J'V9%]-HBGR05^A/
MV8@#18[HXEF7RN,PLV65W *SN"3&@!K^H<F:X.<)S5B8N_13^F#CI6!%;>T^
MWWX"H@'9-K,,4S),%S-SJ@'^SC!W0VY$W;(Z2-D$6VS3DM,X@M\PS^4\RG#F
M4TO*1$2S5_),A2W/ DNXA;)JRW;[$AY+>'V'>E#Y$2:PIDD7,=$?XC26"_SO
M#(U+UY_K/VW?U2Y,QA4Y/[,%SH6V$"3-I_A%G8TT\JC?8^@1@^A SF$HTZ"[
MX7V2?!IX560:A19\&MF4)@C@BR@Y9[.N7"*N/9ZR**9")GM:N;6;9;#EPV'I
ML%KDZ#>Z2>OGDWY^5/FDGS?YI(?1:GY\D==;S>^/CO>.ADB@/CCZ*SC\0%3J
M;XX&,."'HT/XR_M-Z_E[:,=<SXP9#X_>'P>#@_U@[_!@?X1[3&WH>;N/'Z19
M<UC'#=;M#PUD,!:^9386J*[C@.PR]K.IUQ"GC>3=6!R*/0D+:]FYJ=?4E4R5
MJ.K9;"(.&96;1?RH&8>VR!=U99ZE7CJOK3K.XRA4*[$34 =5#5PR,#9RKH4U
MDE?'Y]U!?D1.Y(BOQ8SD-<+JY@+)(R7*:D8QY:H6$(HQ"+&-I)"RC<#+U1J?
MQ&#5<$*,DFIJ:$U]F35VP#PYT?353;IN5X0FC88:)/:CD;6;]0K?EOGQN$I9
M7KY"G24[^ '#/:R77OWY(/-_ZTGYW7N2 11Q40]\*G:\SZLE@ +0JROOH/3M
M#R"))+V%(FXS? 9BC0A>C9^$>MUZ2M?,5&I/4\V"I.+-G"K>]CL_5\_OX[DR
MIXG*KY/Y/)XFC$F9PCX2CE2C1=5^65QO@\2D56[W>PQT;!@)KO:G39/8( ,I
MBT5TR?7)&B$LA]#ZV_,8;(TIY\LB#_=4,47Y]LVDLF_ZE#V$9#:S5T1$:TYQ
MG*BD<-#D+$: &E4L=B#:R>O>D%/=X&9TH/@U#IOO=NPXHXG4@7)4$E-R'-,8
M@C_/,56-2,'BU)&SU[<VCHJ,ND%0,2#<Q@SS89*^HGB5*5XB\GA4(5,T_9N*
M1=3'T(@DQ*L%6R;E1E6@26EZ+Z B YGP73.>W4Y:R3M)1OA&IJK++S*0(BX&
MV$^Q[K/945)#_ED!&;1_XY":XC,+Z.R(1'=H*6XLU7*2X%Q'JNN!5\D IY @
M*@3C4,EA<SO"P+1%%+Z,US$B6U/A4>0$*RE4Z8XBC1YL'8-'U=]5"]'RHGC*
M^STSV^_X7)_?H+!<\W"?%/G?<?%D&D<I6K.1T#87,28L*.1_U0FWPG1K9$H:
M#=]?4A3Q>2Y^[D6!*9!,+*")ZT/@.DM-93H829TE(.4<2Q/93L9NLTB BE&A
M4HJFB%QH_C4=' :$UC:)#QS"EL>X=(<%4MARHBFAA<LE 1RH0![\!)KZQ%;F
MN]I5W]L02\[H&56U(Y-=I,OR;N^9K; C^.^HL8EFWQA,G)PW61N)LHLJGQ@_
M@<'*F;1F;;RYK94R79N%$QG4F+_WR%%4"$DSQ6]B*=>EG5,8DA?PN7O0>OV7
M1Y66^663EKEU?7&3ZF*5ZF .,8HXL]>)^!.7T^X,S6CN%"H,\HMS),P;G^;P
M@=L'17W!>)0_:81.Z[P$Y/N7RQ.L>P&G?G$6/ ^;]KQ!Z@CHC$-%F>A5(W.Y
M[5'-V'.UYF5G Z0=;'C:UM8U;M/Q%(06)0^#+JLDI23&M8S0T%H7_G19$W;J
M@?D2,;>3"<\;5F5)O=CQO;]-M+M]T^XXWGVWE",<[Q['!1=-#=5^2B+I[N+?
M7QJ3:NQP6RZJ/6^E,GBZ1"T2T)W'6A@&<$MLYQ*.%KB^MGQX&VQ'Y?50@,P4
M5(.UK H=>K%EU[YU4:-%X4D0_VKD$492)=EGC'C0W07!L[7[;+O?0]Z54OB@
M3(22)-5.L,^K0!#89!;S&LT\AR#TA$.5GS*/*_NJMK:SC5UFP;W^N!^EB 0S
MCB,7ULT-*6M9"^XX2@93/4[=<DPW1 8+@,&)_ZY_5YIB4Y6[_:3U'62]3S"C
MR,U&Y/MI=$%+"![-)):. UY1O(O?ZL?5@&7DF-MV9AA\BJ0)XC1?GB!D3:&:
MS.1$!T1XNK'#<%14ES2("4ZR N>" D<.T9&:5D>%M)--/W-]'7D&I@UV.X,J
M);8[%$CCO9GE"YRAB-.EO%.L@2[.<MXP^#N^E;F ;0/U>_8P2HH<:VJI9O<T
MF57U?B^*\+PQ)>=LSJ)YDEZ&LKH%ZJO$*&I]V+!0DD>'#6(V#X+LXK?MHRCZ
M0[^EM-,,9G6I@'DJWV1;/J7< @G!CDRZ@!GGZM)-8N5P]M">YU*ZRV-QO69^
M(9*H_46"KO<01@I87!T4 %<>W%00T1-I*,N0!)"Y._T>YF3LOAH*G"MO,Q/0
M"M:2J&@)N\"D?=CCAQ#.<86A6KM,!J\M!DBMV386'.$T",_'+'6,!F@PPW9/
MEPTI=,DQ?YB7NAJ8;RZ61 CMKDHW6;1J?2(^Z:$G^[G[C^V]Z7AOU13C;DBX
M-$>Z$@_^S13O'9M6=\LPY4PKY>D<<[N+#:C@5I*_K9Z/:UEMX=1:+EC$<&OR
MEAT\)^8R+2L8*FP1PF%W;;'<[U.,&IIJ(A.1Y[23+X(<]4[9GK[2!2_4(KDL
MZV>.>JB06?$P00</(1TLK'+>UDR(X-/1K5.#$]J1.H><*C]865>@JHSXM&B:
M]R[N"7-LE D=QSX1O,?*T=X%"_,%&.#_T515R'&UAUSZ_@K<A1[6=A@]4C):
M,SNE:1)KP^ZJ!P:D7XN "%S4D_H]>52HK =.PB*-&_4D/F]X*G4[U,0J&K8'
M)3[$&U*D^LH$]YI#MS[#N P=I+I7NA">%]<L>%F]-2N\#EE]2>PH2D-U=FXM
M2K<BSO[KHXJS_[J)LS\&$(M'HD47SF@+RV59^NQ8K:5GB!$16(ANJ?7\^5:\
M#<+4D;5/XVW6)RP>K-!85Y]XNN[ZZJ1#:JENB\%Z"N7[Q0;<$N:EQ78)I0I9
MDJZX&50^N/7S-O=MXK"@VX60M#<<',:M: WLF;FV0')&YXLB$TJ/-X^;L9BC
M)4BHB"I@4JRKF,0I4JS%R)=+,:A&NQT/[XF3]MG'=)&DU=0=7/4-/G9E="M(
MJ'ZZ%':HN(9AS)36Q%AQZ$B =7\9CI/<G=UBT6UW;;=8 5"+NMYON^7[QA!=
M7TOQ%GDUVE9MY"<FR'^%>"$=I3V?58I*"*U7Z:N:V\QS;(U$UK[IPLS?_,)]
MD9] 5^.*"[>^]FVY>ZM=AN_W5MT5TN(CY2>S/)@DQ60Y+RD[7S92>$*T9?5-
M[=0Z$DQ7T49D]FP^-3<6+AC<W^]X.V_2H&^$'UMM$3]O;&YD+?X7UG?2A(J,
MZ>!Q-C@AJ'<R*6NYE*LO<WNHYJ-A5U='Q^NZT9P_)X70NBO2)"ZV^[UE^R!*
M+.+)TYEB4[AE6RY0D::)IOGKH^))70Z+5)_J'$S'T*U]$7U-L?;JA0T:#L&
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M %"-W4GG+XOW0'%L]S_^.-*<'A;.0+66\[E'+=1J@H2=3",K.46(/++?0^Q
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M+[GCY@0MLHJ>Q=5?>0%W<KE ^&E4QNU:R9O:L[7B(4?CT=Z[8;]'"4DC>L
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M8]O88\\1ZL'QJXG@A[@%#X?)#;=BA+O!'5EEV4<WN/0W7=#P?)VE!\_I3B\
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MXL:RW_D5_<C)C7TNF\3NA7LP8 ]>P -XMB\^C=2 QD+2:#$PO_Y5M2200&#
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MQRUE;*@,S8&')@39167ICNEA@D%\VT^\Q?.%+BW>,U+^2,87['\Y_UJ1\<%
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M<H)<,=T$H;E(D6J?F9*IC_L*(V!;W ;7M4VX,6S"31!*_*9#$FB5(D=H!_#
M3\R<>C::?Q).CQ/(E9%_TL-'@R$QF0V,(@/ SVW(A0Y&9TF*7.OB@0NAX*/G
M"&)L,$#9>F88'(2GS0\A^=75JJ8Y8._N&./&#H;RM&"DJV UK!"*\% ?5PJ/
MV$&\806X)'<5*(T)<F>F8D&66LQ\!H8"192,&9Y[^J3-J>>$51U9L0GO"K-M
MQA+\1P #AEGYZ7(W\!"L,WQT&<_(E0Z9(UIQQA^TW#M(0&]L/B6%A(7V6E+
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M     &)C<G@M,C R-3 V,3$N>'-D4$L! A0#%     @ MX'06O-;FUC]"@
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8=&U02P4&      4 !0 Z 0  )8,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>f8k_061625_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bcrx-20250611.xsd" xlink:type="simple"/>
    <context id="AsOf2025-06-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882796</identifier>
        </entity>
        <period>
            <startDate>2025-06-11</startDate>
            <endDate>2025-06-11</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-06-11" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-06-11" id="Fact000004">0000882796</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-06-11" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-06-11" id="Fact000010">2025-06-11</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-06-11" id="Fact000011">BioCryst Pharmaceuticals, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-06-11" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-06-11" id="Fact000013">000-23186</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-06-11" id="Fact000014">62-1413174</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-06-11" id="Fact000015">4505 Emperor Blvd.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-06-11" id="Fact000016">Suite 200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-06-11" id="Fact000017">Durham</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-06-11" id="Fact000018">NC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-06-11" id="Fact000019">27703</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-06-11" id="Fact000020">(919)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-06-11" id="Fact000021">859-1302</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-06-11" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-06-11" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-06-11" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-06-11" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-06-11" id="Fact000026">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-06-11" id="Fact000027">BCRX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-06-11" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-06-11" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
